Efficacy and Safety of a Modified Vaccinia Ankara-NP+M1 Vaccine Combined with QIV in People Aged 65 and Older: A Randomised Controlled Clinical Trial (INVICTUS)

Background: Pre-existing T cell responses to influenza have been correlated with improved clinical outcomes in natural history and human challenge studies. We aimed to determine the efficacy, safety and immunogenicity of a T-cell directed vaccine in older people. Methods: This was a multicentre, par...

Descripción completa

Detalles Bibliográficos
Autores principales: Butler, Chris, Ellis, Chris, Folegatti, Pedro M., Swayze, Hannah, Allen, Julie, Bussey, Louise, Bellamy, Duncan, Lawrie, Alison, Eagling-Vose, Elizabeth, Yu, Ly-Mee, Shanyinde, Milensu, Mair, Catherine, Flaxman, Amy, Ewer, Katie, Gilbert, Sarah, Evans, Thomas G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402379/
https://www.ncbi.nlm.nih.gov/pubmed/34451976
http://dx.doi.org/10.3390/vaccines9080851

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402379/
https://www.ncbi.nlm.nih.gov/pubmed/34451976
http://dx.doi.org/10.3390/vaccines9080851

Ejemplares similares